Individual Antibody and T Cell Responses to Vaccination and Infection with the 2009 Pandemic Swine-Origin H1N1 Influenza Virus

Preexisting Antibody Response against 2009 Pandemic Influenza H1N1 Viruses in the Taiwanese Population

(2010) C.-Y. Chi et al.   Clinical and Vaccine Immunology

Recipients of Vaccine against the 1976 “Swine Flu” Have Enhanced Neutralization Responses to the 2009 Novel H1N1 Influenza Virus

(2010) Jonathan A. McCullers et al.   CLINICAL INFECTIOUS DISEASES

Cutting Edge: CD4 T Cells Generated from Encounter with Seasonal Influenza Viruses and Vaccines Have Broad Protein Specificity and Can Directly Recognize Naturally Generated Epitopes Derived from the Live Pandemic H1N1 Virus

(2010) K. A. Richards et al.   JOURNAL OF IMMUNOLOGY

A Single Dose of Unadjuvanted Novel 2009 H1N1 Vaccine Is Immunogenic and Well Tolerated in Young and Elderly Adults

(2010) Kawsar R. Talaat et al.   JOURNAL OF INFECTIOUS DISEASES

Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong

(2010) Gannon C. Mak et al.   JOURNAL OF MEDICAL VIROLOGY

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study

(2010) Elizabeth Miller et al.   LANCET

Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza in Pittsburgh, PA, USA

(2010) Shanta M. Zimmer et al.   PLoS One

Influenza A (H1N1) 2009 Antibodies in Residents of New South Wales, Australia, after the First Pandemic Wave in the 2009 Southern Hemisphere Winter

(2010) Gwendolyn L. Gilbert et al.   PLoS One

Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

(2010) R. Xu et al.   SCIENCE

Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets

(2010) Ji-Young Min et al.   VIROLOGY

Qualification of the Hemagglutination Inhibition Assay in Support of Pandemic Influenza Vaccine Licensure

(2009) D. L. Noah et al.   Clinical and Vaccine Immunology

Safety and Immunogenicity of Multiple and Higher Doses of an Inactivated Influenza A/H5N1 Vaccine

(2009) John H. Beigel et al.   JOURNAL OF INFECTIOUS DISEASES

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic

(2009) Gavin J. D. Smith et al.   NATURE

Response to a Monovalent 2009 Influenza A (H1N1) Vaccine

(2009) Michael E. Greenberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus

(2009) Kathy Hancock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population

(2009) J. A. Greenbaum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans

(2009) R. J. Garten et al.   SCIENCE

Seasonal Influenza Vaccine Provides Priming for A/H1N1 Immunization

(2009) G. Del Giudice et al.   Science Translational Medicine

Antibody quantity versus quality after influenza vaccination

(2009) JingQi Feng et al.   VACCINE

Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials

(2009) Frederick G. Hayden et al.   VACCINE

A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects

(2009) Thomas R. Cate et al.   VACCINE

Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses

(2009) Shelly Gulati et al.   Virology Journal

From where did the 2009 'swine-origin' influenza A virus (H1N1) emerge?

(2009) Adrian J Gibbs et al.   Virology Journal